CULVER CITY, Calif.--(BUSINESS WIRE)--
NantHealth, Inc. (NASDAQ: NH), announced an agreement with Northwest
Fire Fighters Benefits Trust (NWFFT), one of the largest firefighter
healthcare trusts in the U.S., to ensure all NWFFT covered plan members
with access to NantHealth’s GPS Cancer and Liquid GPS molecular
profiling tests. Comprehensive molecular information may enable
physicians to make personalized treatment strategies for cancer based on
the individual’s tumor and genetic profile. NWFFT is present in the
states of Alaska, Connecticut, Idaho, Illinois, Nevada and Washington.
“Firefighters risk their lives every day for public safety, often
exposing themselves to carcinogens. Cancer rates are much higher in
firefighters than the average population, and each NWFFT covered member
deserve to have the most innovative and comprehensive tools available to
fight this disease. Ensuring access to GPS Cancer and Liquid GPS tests
from NantHealth is the right things to do,” said Trust Chairman Greg
Markley.
GPS Cancer® offer a comprehensive molecular profile providing precision
insights that include the analysis of a patient’s tumor genome compared
to their normal genome and uses DNA sequencing (20,000 genes, 3 billion
base pairs) with RNA expression (over 200,000 transcripts) unique to
each patient. In addition, pharmacogenomic analysis is provided that may
indicate genetic influences to certain cancer treatment drugs. This
robust test report provides more information that may guide oncologists
to eliminate potential false positive drug targets and tailor treatment
decisions for the best possible outcomes based on a patient’s unique
profile.
Liquid GPS is a blood-based molecular test that allows oncologists to
analyze specific mutational targets when tumor tissue is not available
with cfDNA and cfRNA, and provides the ability to monitor mutational
response to treatment evaluating quantitative cfRNA.
“Cancer is impacting the lives of firefighters at a greater rate than
we’ve seen in the past and as compared with the general population in
the U.S., making it crucial to provide them with the most advanced
healthcare strategies and technology available,” said Dr. Sandeep
“Bobby” Reddy, Chief Medical Officer of NantHealth. “We are steadfast in
our commitment to support the brave men and women of NWFFT, which was
made possible through our deeply trusted partnership with the
International Association of Fire Fighters.”
About NantHealth
NantHealth, a member of the NantWorks ecosystem of companies, provides
leading solutions across the continuum of care for physicians, payers,
patients and biopharmaceutical organizations. NantHealth enables the use
of cutting edge data and technology towards the goal of empowering
clinical decision support and improving patient outcomes. NantHealth’s
comprehensive product portfolio combines the latest technology in
molecular analysis (GPS Cancer® and Liquid GPS®),
payer/provider platforms that exchange information in near-real time
(NaviNet and Eviti), and connected care solutions that deliver Medical
Device Interoperability (MDI). NantHealth’s GPS Cancer®
molecular profiling provides comprehensive DNA & RNA tumor-normal
profiling combined with pharmacogenomics analysis. Liquid GPS®
provides non-invasive testing of cfDNA and cfRNA to monitor cancer
mutations and potentially select targeted therapies, chemotherapies, and
immunotherapies. For more information, please visit www.nanthealth.com.
About Northwest Fire Fighters Benefits Trust
Northwest Fire Fighters Benefits Trust (NWFFT) is a Union-sponsored
Health and Welfare Trust fund available to fire departments across the
United States. Launched in 2013, NWFFT brings firefighters and their
families’ comprehensive, affordable and sustainable health plans. NWFFT
creates a “like risk” pool of firefighters that provides access to both
active and retiree health insurance. NWFFT is currently serving
participating Locals in the states of Alaska, Connecticut, Idaho,
Illinois, Nevada and Washington.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190318005118/en/
NANT
Jen Hodson
562-397-3639
Jen@nant.com
NWFFT
Consultants at DiMartino
1-206-309-NWFF(6933)
becky@dimarinc.com
Source: NantHealth, Inc.